Immunotherapies comprise of a class of cancer therapies that are increasingly used for treatment of several cancer entities. Active immunotherapies encompassing immune checkpoint inhibitors are the most widespread class of immunotherapies, with indications for melanoma, non-small lung cancer, renal cell carcinoma, urothelial carcinoma, head and neck squamous cell carcinoma, and Hodgkin's lymphoma. Immune checkpoint inhibitors…
memo - Magazine of European Medical Oncology Template
Write in a clean editor, then format for memo - Magazine of European Medical Oncology in one click — DocuGuru applies the official Springer Nature template with superscript references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the memo - Magazine of European Medical Oncology format
memo - Magazine of European Medical Oncology is a peer-reviewed journal published by Springer Nature, covering Lymphoma Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Chronic Lymphocytic Leukemia Research.
| Publisher | Springer Nature |
|---|---|
| Reference style | Superscript numbered (Nature) Superscript — small raised numerals in the text 1. Smith, A., Jones, B. & Lee, C. A representative article title. memo - Magazine of European Medical Oncology 12, 45–58 (2023).
Formats any DOI in memo - Magazine of European Medical Oncology style. No sign-up. |
| Publishes research in | Lymphoma Diagnosis and Treatment Lung Cancer Treatments and Mutations Chronic Lymphocytic Leukemia Research Cancer Genomics and Diagnostics Acute Myeloid Leukemia Research |
| ISSN | 1865-5041 |
| Citation impact (2-yr) | 0.76 |
| h-index | 26 |
| i10-index | 81 |
| Total citations | 3,322 |
| Article processing charge | $4,390 |
| Top institutions publishing here | Medical University of Vienna |
| Journal website | www.springer.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in memo - Magazine of European Medical Oncology per year
Citation impact of memo - Magazine of European Medical Oncology by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in memo - Magazine of European Medical Oncology
Summary Background The prevalence of malnutrition in cancer patients ranges from about 20% to more than 70%. However, 10–20% of cancer patients’ deaths are related to malnutrition, not the malignancy itself. To reverse the pattern of weight loss, improve the patients’ quality of life, reduce the treatment toxicity, the psychological stress and the risk of…
Imaging plays a major role in the diagnosis, treatment, and follow-up of breast cancer. Findings that require further assessment will be detected both at screening and curative mammography. Most findings that are further worked up tend to yield benign diagnoses. Consequently, there is an ongoing search for new tools to reduce recalls and unnecessary biopsies…
Aggressive lymphomas are a heterogeneous group of malignancies reflecting clinical, biological and pathological diversity. Diffuse large B‑cell lymphoma is the most common histological subtype and therefore will constitute the key aspect in this article. This lymphoma affects patients of all age groups with wide range presentations concerning localization, morphology and molecular mechanisms. The median age…
Summary Identification of the underlying genetic and epigenetic alterations in an increasing number of tumors of the nervous system is contributing to a more clinically relevant classification. In the following article, the 7 cIMPACT-NOW publications, which adumbrate the upcoming 5th edition of the WHO Classification of Tumours of the Central Nervous Sytem are summarized.